(MedPage Today) — Brazilian patients with systemic sclerosis (SSc) had a lower immune response to the recombinant herpes zoster vaccine (Shingrix) compared with healthy controls in a randomized trial, casting doubt on the vaccine’s long-term effectiveness…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
